AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2018

Jun 27, 2018

Director's Dealing

Opens in your device viewer

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2018-06-22

Reporting Person: Vos Ellen O'Connor (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-22	Common Stock	P	400	$10.35	Acquired	9734	Direct
2018-06-22	Common Stock	P	50	$10.29	Acquired	9784	Direct
2018-06-25	Common Stock	P	1100	$10.47	Acquired	10884	Direct
2018-06-25	Common Stock	P	250	$10.72	Acquired	11134	Direct